INTRODUCTION
Trematode flatworms of the genus Schistosoma are the causative agents of schistosomiasis, a major tropical parasitic disease. Adult schistosomes reside in the blood vessels of the host, where, among other functions, they must take up nutrients and dispose of toxic metabolites.
The current drug of choice against schistosomiasis is praziquantel (PZQ), a pyrazinoisoquinoline anthelmintic that is active against all schistosome species, shows minimal side effects, and is also effective against other trematode and cestode infections [1] [2] [3] [4] . Indeed, because of these advantages over other chemotherapeutics, PZQ has in recent years become effectively the only antischistosomal commercially available [5, 6] , making the prospect of emerging resistance to PZQ particularly troubling [7] .
The export of biomolecules, including metabolite disposal, is commonly performed by members of the ATP-binding-cassette (ABC) superfamily of proteins. One of the members of this class, P-glycoprotein (Pgp), is an ATP-dependent efflux pump that in vertebrates serves as one of a set of major membrane transporters for toxic and xenobiotic compounds. Pgp is the product of the multidrug-resistance 1 (MDR1, ABCB1) gene, which is amplified and overexpressed in certain mammalian tumor cells that show broad drug resistance [8] [9] [10] [11] . Pgp expression levels and allele frequencies are also altered in anthelmintic-resistant populations of nematodes [13] [14] [15] [16] [17] [18] , and the potential roles of Pgp in parasite drug resistance and as a possible site for pharmacological modulation in helminths have recently been reviewed [19] [20] [21] .
Investigation of schistosome and platyhelminth Pgps and other drug transporters has been limited. Several years ago, two S. mansoni cDNAs coding for ABC proteins were cloned and sequenced [22] . One of these cDNAs (SMDR2) encodes a Pgp-like protein, with 12 transmembrane regions and two ATP-binding domains predicted. A partial ABC transporter sequence from the liver fluke, Fasciola hepatica has also been reported [23] . Sato et al [24, 25] have used fluorescent substrates of Pgp and multidrug resistance-like proteins (MRPs) to visualize the excretory system of S. mansoni. They also used compounds known to inhibit these transporter activities in mammals to perturb excretory function in schistosomes. PZQ has dramatic effects on excretion of resorufin, a likely Pgp substrate [26] . Thus, schistosome excretory activity, which is probably mediated by a Pgp-like molecule such as SMDR2, can be altered by PZQ, as well as other pharmacological and environmental agents. Furthermore, PZQ has been shown [27] value, it is independent of the affinity and concentration of the reference substrate).
Here, we examine the relationship between PZQ and schistosome Pgp in more detail, by examining the expression patterns of SMDR2 RNA and anti-Pgp immunoreactive protein in response to PZQ. We find that exposure of adult schistosomes to a sub-lethal concentration of PZQ results in transiently increased expression of the SMDR2 transcript as well as a ~140 kDa band that is immunolabeled by a monoclonal antibody against conserved epitopes of Pgp. In addition, we show that adults from EE2, an Egyptian S. mansoni isolate with reduced susceptibility to PZQ [28] , expresses significantly higher levels of SMDR2 RNA and anti-Pgp immunoreactive protein than adults from control, PZQ-sensitive strains.
MATERIALS AND METHODS

Reagents
Praziquantel (Sigma) was dissolved in dimethyl sulfoxide for stock solutions, which were subsequently diluted to an appropriate concentration in culture media. The mouse monoclonal antibody against Pgp [29] was from Abcam (C219). The anti-rabbit tubulin antibody was from Santa Cruz Biotechnology (H-235).
Isolation and treatment of adult schistosomes
Female Swiss Webster mice infected with S. mansoni (NMRI strain) were obtained from the NIAID Schistosomiasis Resource Center at the Biomedical Research Institute in Rockville, MD. Adult S. mansoni were collected by perfusion, as described [30] , and maintained in RPMI (Invitrogen) plus 10% FBS (Sigma) at 37°C and 5% CO 2 . Following an overnight incubation, worms were exposed to PZQ for variable periods and at different concentrations. In some experiments, the mixed worm population was separated into male and female groups, and then exposed to PZQ for various time points. Following incubation, adults were either used for RNA and protein extraction immediately, or quick-frozen in liquid nitrogen and stored at -80°C until use. Both the EE2 and CD1 worms were obtained from the Theodor Bilharz Research Institute, Giza, Egypt. EE2 worms were originally isolated from Egyptian patients not cured following three successive doses of PZQ. These worms were also shown to exhibit an approximately threefold reduction in PZQ susceptibility when tested in murine infections [31] as well as reduced susceptibility to PZQ in vitro [28] . Subsequently, following maintenance of the EE2 isolate over several years and through multiple laboratory life cycles without exposure to PZQ, EE2 worms continued to exhibit approximately three-fold reduced susceptibility to PZQ compared to PZQsusceptible worms [32] . The PZQ-susceptible CD1 isolate has been maintained at the Theodor Bilharz Research Institute, Giza, Egypt for more than two decades, and has not knowingly been in contact with PZQ. These adult worms were recovered by perfusion, placed in RNAlater (Ambion), and stored first at room temperature and then at -20°C until use.
RNA extractions and RT-PCR
RNA was extracted from adult schistosomes using either RNAqueous 
Real-time RT-PCR
Real-time PCR using SYBR Green was performed using the Brilliant SYBR Green QPCR Reagent kit (Statagene) on an Opticon 2 Real-Time PCR Detection System (BioRad). S. mansoni glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a reference sequence in these experiments. Primers used for amplification of SMDR2 were: SmMDR2-Sy1
(5′-TGCTCTAGTCGGTTCTAGTGGTTCTG-3′) and SmMDR2-Sy2 (5′-GCATTAGCTTTGATGGCAGCTTCG-3′). Primers used for amplification of GAPDH cDNA Experiments were performed on either an Opticon 2 Real-Time PCR Detection System (BioRad)
or an Applied Biosystems 7500 Fast system. The templates for those experiments using CD1
and EE2 were amplified, adapter-ligated cDNA pools made from CD1 and EE2 total RNA.
These cDNA samples were made using primers and protocols of Matz Method B [33] .
Quantitative analysis of expression levels using this approach have been validated using "virtual northern blots", and accurately reflect differential RNA expression patterns [34] . An equal amount of RNA from the two isolates was reverse-transcribed and amplified by PCR using Superscript II (Invitrogen) and the adapter-primers described in [33] , and amplified by PCR.
These cDNA pools were diluted 1:50 in water prior to use as templates for real time PCR experiments.
Analysis of real time RT-PCR data was carried out using the 2 -ΔΔ C t method, with appropriate calibrators and corrections for amplification efficiency, as described [35] . A one sample t-test was used to determine statistically significant differences from a value of 1 (P ≤ 0.05), which would indicate no change in expression. Data are presented as mean ± SEM.
Protein extraction and analysis
Protein was extracted using the PARIS miRVANA kit (Ambion) using the manufacturer's instructions. Additionally, a protease inhibitor mix (Sigma) was added to the cell disruption buffer. Protein concentrations were determined using the Bio-Rad Protein assay (Bio-rad). Equal Adult S. mansoni in culture were exposed to a sublethal concentration of PZQ (100 nM) for 3h. Total RNA was extracted from these parasites, as well as controls, and reversetranscribed into cDNA using random hexamers as primers. Initially, we found that a mixedsex population of worms treated with PZQ showed increased levels of SMDR2 RNA as determined by RT-PCR. Further experiments in which male and female worms were separated prior to PZQ exposure showed that the increase in SMDR2 RNA levels is occurring only in males ( Fig. 1) . Real-time RT-PCR analysis shows a significant 3.37 ± 0.35-fold increase in SMDR2 expression in males following 3 h PZQ exposure. However, by 24 h, SMDR2 mRNA expression levels have returned to baseline levels (relative SMDR2 expression = 0.88 ± 0.14).
We also typically see 2-5-fold higher SMDR2 RNA levels in control females (ie, incubated in RPMI medium without PZQ) compared to males, consistent with earlier observations by others [22] . For example, relative SMDR2 RNA levels are 3.0 ± 0.43-fold higher in 3h control female worms than in 3h control males (n = 4). There is also some indication of an increase in relative SMDR2 mRNA expression following a 48-h PZQ exposure, although the change is not significant (1.83 ± 0.66). Interestingly, a mixed-sex population of adults appears to show higher relative levels of SMDR2 RNA following 6 days in 100 nM PZQ (2.81-fold).
However, as the elimination half-life of PZQ and its metabolites is on the order of hours [34] , the relevance of any such long-term effects in actual treatment regimens is not clear.
Adult males exposed to different concentrations of PZQ show increased SMDR2
mRNA expression at 3 h, as measured by quantitative RT-PCR. Thus, at 300 nM PZQ, SMDR2 mRNA expression increases 2.17-fold, while 500 nM PZQ results in a 5.6-fold increase. As with 100 nM PZQ, the increase is transient. After exposure to 300 nM PZQ for 24 h, the ratio of SMDR2 mRNA expression compared to controls is 0.6. The level of expression following 24 h exposure to 500 nM PZQ could not be measured accurately due to excessive worm lethality. We have not yet determined a minimal PZQ concentration that can produce the transient increase in SMDR2 mRNA expression.
Levels of an S. mansoni anti-Pgp immunoreactive protein increase in males in response to
PZQ.
We have used western blots to measure relative levels of schistosome SMDR2 protein (or a cross-reacting Pgp-like protein species). For these experiments, we used a monoclonal antibody against mammalian Pgp [29] . This antibody targets two Pgp epitopes that are largely (Fig. 2) . Average Pgp band intensity (relative to β-tubulin) increases 1.92 ± 0.57-fold (n = 5; P = 0.024, paired t-test). We sometimes see evidence for an increase in band intensity in females as well, though the change is not significant. Tubulin levels did not increase in response to PZQ. Interestingly, additional, anti-Pgp-immunoreactive bands of slightly lower molecular weight are sometimes apparent in these experiments following PZQ exposure, in both males and females (Fig. 2 ). An increase is also apparent in male worms exposed to PZQ for 48 h, though to a lesser extent, and no detectable changes in expression levels of anti-Pgp immunoreactivity are observed in S. mansoni exposed to PZQ for either 15 min or 3 h (data not shown). Interestingly, the higher level of SMDR2 RNA found in females does not appear to be reflected at the protein level, as there is no significant difference in relative band intensity (compared to β-tubulin) between control males and females.
Immunohistochemical labeling was used to localize changes in schistosome anti-Pgp immunoreactivity in whole mounts of adult schistosomes. Adult S. mansoni males exposed to 100 nM PZQ for 18 h showed prominent anti-Pgp immunoreactivity within the gut (Fig. 3A) and this labeling was also present surrounding the gut (Fig. 3D ). This immunoreactivity was not detected in untreated control worms (Fig. 3B) , nor in samples not incubated with the primary antibody (Fig. 3C) .
SMDR2 RNA and an anti-Pgp-immunoreactive protein are expressed at higher levels in a schistosome isolate with reduced PZQ susceptibility.
We examined the expression levels of S. mansoni SMDR2 RNA and anti-Pgp immunoreactive protein in adult EE2 and CD1 schistosomes. EE2 is an Egyptian isolate with reduced susceptibility to PZQ, while CD1 is a PZQ-sensitive isolate that has never been exposed to PZQ [38] . Semiquantitative RT-PCR indicates that SMDR2 RNA is expressed at higher levels in the EE2 worms (Fig. 4a) . In contrast, 18S ribosomal RNA levels in EE2 and CD1 worms are relatively constant. Based on quantitation of band intensity and normalization to 18S band intensity, SMDR2 RNA is expressed at a 2.68 ± 0.75 fold higher level in EE2 worms compared with CD1 worms (P = 0.013, two-tailed t-test, n=5). SMDR2 RNA is also expressed at higher levels in EE2 worms than in adult worms from the NMRI strain of S. mansoni. Quantitation of band intensity, with normalization to 18S band intensity, indicates SMDR2 RNA is expressed at a 2.92-fold higher level in EE2 adults than in NMRI worms.
We also tested relative SMDR2 RNA levels using real time quantitative PCR (Fig. 4b) . In this case, highly representative, amplified cDNA samples [33] made from EE2 and CD1 schistosomes were used as templates. These types of cDNA samples have been verified by others to be accurate reflections of differential gene expression [34] . From these experiments, we determined that the normalized expression ratio of SMDR2 RNA, using GAPDH as the reference sequence, is 12.4 in the EE2 isolate compared to the CD1 isolate.
Anti-Pgp immunoreactive protein is also expressed at higher levels in the EE2 isolate (Fig. 5) . In contrast, levels of β-tubulin are equivalent in EE2 and CD1 worms.
This increased level of putative Pgp expression has been observed in four separate blots.
Schistosome anti-Pgp immunoreactivity is also higher in EE2 adults compared to adult worms from the NMRI strain of S. mansoni (data not shown).
DISCUSSION:
Multidrug resistance was originally characterized in mammalian tumor cells that had been selected for resistance to a single drug, but which also showed an unpredictable cross-resistance against several structurally unrelated compounds. A major mediator of this effect is Pgp, an ATP-dependent transporter that functions to remove toxic and xenobiotic compounds from cells. Alterations of Pgp expression levels and allele frequencies have also been implicated in drug resistance in various parasites, including helminths [17, 18] . We have demonstrated in this report that treatment of schistosomes It remains to be determined whether this increased Pgp level is involved in the mechanism by which PZQ resistance can develop, or is, instead, simply a correlate of this process. However, the apparent upregulation of SMDR2 RNA and Pgp protein in adult parasites following exposure to PZQ, as well as the recent observation that PZQ is an inhibitor of mammalian Pgp [27] Real time RT-PCR on S. mansoni adult males and females treated with 100 nM PZQ in vitro for 3 hours, 24 hours, or 48 hours using primers to SMDR2 and GAPDH. The 2 -ΔΔ C t method [32] was used to determine the relative expression ratio between SMDR2 and GAPDH mRNAs.
Asterisk indicates a statistically significant difference from a value of 1, which would indicate no change (one sample t-test, P = 0.001). 
